Eliana Rulli (E Rulli)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Scientific reports

Cancers

Cancer

International journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Gianluigi Ferretti, Elisabetta Cretella, Lorenzo Gianni, Claudia Bighin, Angela Toss, Claudio Zamagni, Patrizia Vici, Costanza De Rossi, Antonio Russo, Giancarlo Bisagni, Antonio Frassoldati, Lucia Borgato, Anna Cariello, Claudia Cappelletti, Roberto Bordonaro, Saverio Cinieri, Alessandra Modena, Matteo Valerio, Maria Francesca Alvisi, Irene De Simone, Francesca Galli, Eliana Rulli, Anna Santoni, Fabrizio Nicolis
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study. Cancers 15 (19) (2023)
Eliana Rulli, Luciano Quaranta, Ivano Riva, Davide Poli, Lital Hollander, Fabio Galli, Andreas Katsanos, Francesco Oddone, Valter Torri, Robert N Weinreb, null null
Author Correction: Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study. Scientific reports 10 (1) (2020)
Federica Guffanti, Maria Francesca Alvisi, Elisa Caiola, Francesca Ricci, Marcella De Maglie, Sabina Soldati, Monica Ganzinelli, Alessandra Decio, Raffaella Giavazzi, Eliana Rulli, Giovanna Damia
Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts. Cancers 12 (9) (2020)
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Sara Lonardi, Monica Ronzoni, Bruno Massidda, Vittorina Zagonel, Nicoletta Pella, Claudia Mucciarini, Roberto Labianca, Maria Teresa Ionta, Irene Bagaloni, Enzo Veltri, Pietro Sozzi, Sandro Barni, Vincenzo Ricci, Luisa Foltran, Mario Nicolini, Edoardo Biondi, Annalisa Bramati, Daniele Turci, Silvia Lazzarelli, Claudio Verusio, Francesca Bergamo, Alberto Sobrero, Luciano Frontini, Mauro Magnani
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Scientific reports 10 (1) (2020)
Ivano Riva, Lorenzo Legramandi, Eliana Rulli, Anastasios G Konstas, Andreas Katsanos, Francesco Oddone, Robert N Weinreb, Luciano Quaranta, null null
Author Correction: Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients. Scientific reports 10 (1) (2020)
Federica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, Toni Ibrahim, Stefano Tamberi, Cristina Matteo, Eliana Rulli, Danila Comandini, Emanuela Palmerini, Giacomo Giulio Baldi, Andrea DeCensi, Marina Bergaglio, Domenico Marra, Emanuela Marchesi, Giacomo Siri, Maurizio D'Incalci, Giovanni Grignani
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group. Cancer 126 (21) (2020)
Ivano Riva, Lorenzo Legramandi, Eliana Rulli, Anastasios G Konstas, Andreas Katsanos, Francesco Oddone, Robert N Weinreb, Luciano Quaranta, null null
Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients. Scientific reports 9 (1) (2019)
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Sara Lonardi, Monica Ronzoni, Bruno Massidda, Vittorina Zagonel, Nicoletta Pella, Claudia Mucciarini, Roberto Labianca, Maria Teresa Ionta, Irene Bagaloni, Enzo Veltri, Pietro Sozzi, Sandro Barni, Vincenzo Ricci, Luisa Foltran, Mario Nicolini, Edoardo Biondi, Annalisa Bramati, Daniele Turci, Silvia Lazzarelli, Claudio Verusio, Francesca Bergamo, Alberto Sobrero, Luciano Frontini, Mauro Magnani
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Scientific reports 9 (1) (2019)
Eliana Rulli, Luciano Quaranta, Ivano Riva, Davide Poli, Lital Hollander, Fabio Galli, Andreas Katsanos, Francesco Oddone, Valter Torri, Robert N Weinreb, null null
Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study. Scientific reports 8 (1) (2018)
Marina Elena Cazzaniga, L Cortesi, A Ferzi, L Scaltriti, F Cicchiello, M Ciccarese, S Della Torre, F Villa, M Giordano, C Verusio, M Nicolini, A R Gambaro, L Zanlorenzi, E Biraghi, E Casini, L Legramandi, Eliana Rulli
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now? International journal of breast cancer 2017 (2017)

Eliana Rulli.css-eqlu8i{font-size:small;padding-left:4px;} (E Rulli)

Publication Activity (10 Years)

Top Topics

Top Venues

Eliana Rulli (E Rulli)